title: Impact of proficiency testing program for laboratories conducting early diagnosis of HIV-1 infection in infants in low- to middle-income countries.
abstract: A voluntary, cost-free external quality assessment (EQA) program established by the U.S. Centers for Disease Control and Prevention (CDC) was implemented to primarily monitor the performance of laboratories conducting HIV Early Infant Diagnosis (EID) from dried blood spots (DBS) in low- to middle-income countries since 2006. Ten blind DBS proficiency test (PT) specimens and 100 known HIV-positive and -negative DBS specimens (to be used as internal controls) were shipped triannually to participating laboratories with reports for the PT specimens due within 30 days. The participant's results and a summary of the performance of all participating laboratories and each diagnostic method were provided after each test cycle. Enrollment in the CDC PT program expanded progressively from 17 laboratories from 11 countries in 2006 to include 136 laboratories from 41 countries at the end of 2012. Despite external pressures to test and treat more children while expanding EID programs, mean PT test scores significantly improved over time as demonstrated by the upward trend from mid-2006 to the end of 2012 (P=0.001) and the increase in the percentage of laboratories scoring 100% (P=0.003). The mean test scores plateaued over the past 10 testing cycles, ranging between 98.2% and 99.7%, and discordant test results still occur but at a rate of no higher than 2.6%. Analysis of these test results suggests a positive impact of proficiency testing on the testing performance of the participating laboratories, and a continuous training program and proficiency testing participation may translate into laboratories improving their testing accuracy.
authors.affiliation: International Laboratory Branch, Division of Global HIV/AIDS, Center for Global Health, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, Atlanta, Georgia, USA.
authors.forename: Albert
authors.initials: A
authors.lastname: Garcia
authors.forename: Shambavi
authors.initials: S
authors.lastname: Subbarao
authors.forename: Guoqing
authors.initials: G
authors.lastname: Zhang
authors.forename: Linda
authors.initials: L
authors.lastname: Parsons
authors.forename: John
authors.initials: J
authors.lastname: Nkengasong
authors.forename: Chin-Yih
authors.initials: CY
authors.lastname: Ou
authors.forename: Dennis
authors.initials: D
authors.lastname: Ellenberger
mesh_terms: D001769:Blood / Q000821:virology; D002487:Centers for Disease Control and Prevention, U.S.; D019411:Clinical Laboratory Techniques / Q000379:methods* / Q000592:standards*; D003890:Desiccation; D003906:Developing Countries; D042241:Early Diagnosis; D015658:HIV Infections / Q000175:diagnosis* / Q000821:virology; D015497:HIV-1 / Q000302:isolation & purification*; D006302:Health Services Research / Q000639:trends; D006801:Humans; D007223:Infant; D059021:Laboratory Proficiency Testing; D011785:Quality Assurance, Health Care / Q000639:trends; D013048:Specimen Handling / Q000379:methods / Q000592:standards; D014481:United States